Bailard’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-12,976
| Closed | -$1.08M | – | 800 |
|
|
2022
Q4 | $1.08M | Hold |
12,976
| – | – | 0.04% | 250 |
|
|
2022
Q3 | $1.03M | Hold |
12,976
| – | – | 0.04% | 242 |
|
|
2022
Q2 | $964K | Hold |
12,976
| – | – | 0.04% | 249 |
|
|
2022
Q1 | $1.17M | Buy |
12,976
+8,467
| +188% | +$761K | 0.04% | 248 |
|
|
2021
Q4 | $505K | Buy |
4,509
+1,449
| +47% | +$162K | 0.02% | 405 |
|
|
2021
Q3 | $385K | Hold |
3,060
| – | – | 0.01% | 458 |
|
|
2021
Q2 | $414K | Buy |
3,060
+60
| +2% | +$8.12K | 0.01% | 447 |
|
|
2021
Q1 | $407K | Hold |
3,000
| – | – | 0.02% | 434 |
|
|
2020
Q4 | $422K | Hold |
3,000
| – | – | 0.02% | 364 |
|
|
2020
Q3 | $334K | Hold |
3,000
| – | – | 0.02% | 360 |
|
|
2020
Q2 | $336K | Hold |
3,000
| – | – | 0.02% | 344 |
|
|
2020
Q1 | $232K | Sell |
3,000
-60
| -2% | -$4.64K | 0.02% | 384 |
|
|
2019
Q4 | $291K | Hold |
3,060
| – | – | 0.02% | 416 |
|
|
2019
Q3 | $233K | Sell |
3,060
-601
| -16% | -$45.8K | 0.01% | 446 |
|
|
2019
Q2 | $321K | Hold |
3,661
| – | – | 0.02% | 399 |
|
|
2019
Q1 | $331K | Buy |
3,661
+60
| +2% | +$5.43K | 0.02% | 400 |
|
|
2018
Q4 | $258K | Hold |
3,601
| – | – | 0.02% | 445 |
|
|
2018
Q3 | $345K | Buy |
+3,601
| New | +$345K | 0.02% | 448 |
|